A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy?

AbstractObjective: The benefit of adjuvant therapy (AT) remains controversial in stage IB gastric cancer (GC). This study aimed to offer a reference for the rational indications of AT.Methods: We r...